MDS-话题@MedSci

#MDS#

57篇内容 | 1537人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1842795, encodeId=bf1d1842e95ef, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=Br J Haematol：阿扎胞苷，7号染色体异常的高风险MDS患者的福音？, objectType=article, longId=146868, objectId=51c81468682a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51c81468682a, replyNumber=0, likeNumber=31, createdTime=2018-09-01, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51c81468682a, moduleTitle=Br J Haematol：阿扎胞苷，7号染色体异常的高风险MDS患者的福音？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51c81468682a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842793, encodeId=d0361842e93c3, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=CLIN CANCER RES：MDSC产生的一氧化氮损伤FcR介导的NK细胞功能, objectType=article, longId=136672, objectId=19ee1366e247, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19ee1366e247, replyNumber=0, likeNumber=40, createdTime=2018-10-04, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19ee1366e247, moduleTitle=CLIN CANCER RES：MDSC产生的一氧化氮损伤FcR介导的NK细胞功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19ee1366e247)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842789, encodeId=33831842e89c1, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=Leuk Lymphoma：AML和MDS患者：万古霉素耐药肠球菌获得和感染的风险因素, objectType=article, longId=108887, objectId=cecc10888edb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cecc10888edb, replyNumber=0, likeNumber=34, createdTime=2017-12-22, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cecc10888edb, moduleTitle=Leuk Lymphoma：AML和MDS患者：万古霉素耐药肠球菌获得和感染的风险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cecc10888edb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842791, encodeId=dd9d1842e91da, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=Cancer Res：二甲双胍阻断MDSC的免疫抑制作用，在卵巢癌治疗中发挥作用, objectType=article, longId=130129, objectId=871613012915, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=871613012915, replyNumber=0, likeNumber=38, createdTime=2018-06-24, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=871613012915, moduleTitle=Cancer Res：二甲双胍阻断MDSC的免疫抑制作用，在卵巢癌治疗中发挥作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=871613012915)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842788, encodeId=7bd11842e88d2, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=CLIN CANCER RES：TRAIL-R2激动性抗体DS-8273a靶向MDSC治疗肿瘤患者, objectType=article, longId=104298, objectId=69ac10429860, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69ac10429860, replyNumber=0, likeNumber=39, createdTime=2017-09-25, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69ac10429860, moduleTitle=CLIN CANCER RES：TRAIL-R2激动性抗体DS-8273a靶向MDSC治疗肿瘤患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69ac10429860)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842785, encodeId=3c4a1842e8596, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=Br J Haematol：难治/复发性HR-MDS合并AML-TD：高剂量来那度胺有效吗？, objectType=article, longId=93849, objectId=196093849f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=196093849f6, replyNumber=0, likeNumber=33, createdTime=2018-03-06, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=196093849f6, moduleTitle=Br J Haematol：难治/复发性HR-MDS合并AML-TD：高剂量来那度胺有效吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=196093849f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842787, encodeId=b7431842e87c9, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=Am J Hematol：去甲基化药物治疗MDS：完全细胞遗传学响应对结局的影响, objectType=article, longId=102210, objectId=e9a410221037, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9a410221037, replyNumber=0, likeNumber=29, createdTime=2017-09-13, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9a410221037, moduleTitle=Am J Hematol：去甲基化药物治疗MDS：完全细胞遗传学响应对结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9a410221037)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842786, encodeId=33cc1842e8631, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=聚焦|上海CMEF会议论坛：如何应对MDSAP审核, objectType=article, longId=98902, objectId=99d698902ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99d698902ce, replyNumber=0, likeNumber=39, createdTime=2018-04-15, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99d698902ce, moduleTitle=聚焦|上海CMEF会议论坛：如何应对MDSAP审核, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99d698902ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842784, encodeId=50231842e8471, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=JAMDA:使用MDS3.0对暂居养老院的老人进行ADL评估, objectType=article, longId=51418, objectId=c8a951418e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8a951418e5, replyNumber=0, likeNumber=27, createdTime=2016-02-11, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8a951418e5, moduleTitle=JAMDA:使用MDS3.0对暂居养老院的老人进行ADL评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8a951418e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842782, encodeId=098d1842e82ff, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=ASH 2014：中高危MDS和CMML的临床难题仍待探索, objectType=article, longId=44413, objectId=7a2c44413b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a2c44413b4, replyNumber=0, likeNumber=45, createdTime=2014-12-27, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a2c44413b4, moduleTitle=ASH 2014：中高危MDS和CMML的临床难题仍待探索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a2c44413b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842781, encodeId=77511842e815f, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=ASH 2014：来那度胺诱导伴有5q-的MDS患者CSNK1A1泛素化和降解, objectType=article, longId=44384, objectId=3eee44384ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3eee44384ee, replyNumber=0, likeNumber=29, createdTime=2015-05-04, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3eee44384ee, moduleTitle=ASH 2014：来那度胺诱导伴有5q-的MDS患者CSNK1A1泛素化和降解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3eee44384ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842783, encodeId=d9bc1842e83f5, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=Blood: 鸡生蛋or蛋生鸡？MDS or AML？, objectType=article, longId=47651, objectId=8d1c4e65175, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d1c4e65175, replyNumber=0, likeNumber=34, createdTime=2016-01-08, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d1c4e65175, moduleTitle=Blood: 鸡生蛋or蛋生鸡？MDS or AML？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d1c4e65175)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842780, encodeId=b1591842e80e1, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=MDS患者应用铁螯合剂改善造血及生存, objectType=article, longId=25223, objectId=e91325223ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e91325223ad, replyNumber=0, likeNumber=29, createdTime=2014-08-23, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e91325223ad, moduleTitle=MDS患者应用铁螯合剂改善造血及生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e91325223ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842779, encodeId=5e5a1842e7968, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=MDS 2013：伴HP感染的帕金森病患者治疗效果更佳, objectType=article, longId=21585, objectId=c426215855d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c426215855d, replyNumber=0, likeNumber=28, createdTime=2014-03-04, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c426215855d, moduleTitle=MDS 2013：伴HP感染的帕金森病患者治疗效果更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c426215855d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842778, encodeId=39f11842e7831, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=MDS 2013：帕金森病进程存在高度可变性, objectType=article, longId=21583, objectId=1ffc2158324, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ffc2158324, replyNumber=0, likeNumber=23, createdTime=2014-05-07, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ffc2158324, moduleTitle=MDS 2013：帕金森病进程存在高度可变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ffc2158324)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842777, encodeId=59191842e7742, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=Cancer Res: 研究发现癌症中免疫抑制的关键细胞MDSC, objectType=article, longId=3793, objectId=8d243e93e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d243e93e9, replyNumber=0, likeNumber=33, createdTime=2012-03-18, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d243e93e9, moduleTitle=Cancer Res: 研究发现癌症中免疫抑制的关键细胞MDSC, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d243e93e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842776, encodeId=73a51842e76c7, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=多维尺度分析MDS实践操作, objectType=article, longId=2302, objectId=580623023d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=580623023d, replyNumber=0, likeNumber=46, createdTime=2011-05-16, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=580623023d, moduleTitle=多维尺度分析MDS实践操作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=580623023d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

MDS

2020-05-29

d830372 (审核中...)

前往app查看评论内容

#MDS#

Br J Haematol：阿扎胞苷，7号染色体异常的高风险MDS患者的福音？

2018-09-01

d830372 (审核中...)

前往app查看评论内容

#MDS#

CLIN CANCER RES：MDSC产生的一氧化氮损伤FcR介导的NK细胞功能

2018-10-04

d830372 (审核中...)

前往app查看评论内容

#MDS#

Leuk Lymphoma：AML和MDS患者：万古霉素耐药肠球菌获得和感染的风险因素

2017-12-22

d830372 (审核中...)

前往app查看评论内容

#MDS#

Cancer Res：二甲双胍阻断MDSC的免疫抑制作用，在卵巢癌治疗中发挥作用

2018-06-24

d830372 (审核中...)

前往app查看评论内容

#MDS#

CLIN CANCER RES：TRAIL-R2激动性抗体DS-8273a靶向MDSC治疗肿瘤患者

2017-09-25

d830372 (审核中...)

前往app查看评论内容

#MDS#

Br J Haematol：难治/复发性HR-MDS合并AML-TD：高剂量来那度胺有效吗？

2018-03-06

d830372 (审核中...)

前往app查看评论内容

#MDS#

Am J Hematol：去甲基化药物治疗MDS：完全细胞遗传学响应对结局的影响

2017-09-13

d830372 (审核中...)

前往app查看评论内容

#MDS#

聚焦|上海CMEF会议论坛：如何应对MDSAP审核

2018-04-15

d830372 (审核中...)

前往app查看评论内容

#MDS#

JAMDA:使用MDS3.0对暂居养老院的老人进行ADL评估

2016-02-11

d830372 (审核中...)

前往app查看评论内容

#MDS#

ASH 2014：中高危MDS和CMML的临床难题仍待探索

2014-12-27

仁者大医 (审核中...)

前往app查看评论内容

#MDS#

ASH 2014：来那度胺诱导伴有5q-的MDS患者CSNK1A1泛素化和降解

2015-05-04

d830372 (审核中...)

前往app查看评论内容

#MDS#

Blood: 鸡生蛋or蛋生鸡？MDS or AML？

2016-01-08

d830372 (审核中...)

前往app查看评论内容

#MDS#

MDS患者应用铁螯合剂改善造血及生存

2014-08-23

d830372 (审核中...)

前往app查看评论内容

#MDS#

MDS 2013：伴HP感染的帕金森病患者治疗效果更佳

2014-03-04

d830372 (审核中...)

前往app查看评论内容

#MDS#

MDS 2013：帕金森病进程存在高度可变性

2014-05-07

d830372 (审核中...)

前往app查看评论内容

#MDS#

Cancer Res: 研究发现癌症中免疫抑制的关键细胞MDSC

2012-03-18

d830372 (审核中...)

前往app查看评论内容

#MDS#

多维尺度分析MDS实践操作

2011-05-16

科室
- - 订阅+
  - 更多科室
工具
服务